Mapping the Interaction Anatomy of BmP02 on Kv1.3 Channel

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• The potassium channel Kv1.3 is crucial for T lymphocyte activation and a target for autoimmune disease therapies.
• BmP02, a peptide from Chinese scorpion venom, is a known potent Kv1.3 blocker, but its inhibitory mechanism is not fully understood.

Purpose of the Study:

• To elucidate the molecular recognition mechanism between the peptide BmP02 and the potassium channel Kv1.3.
• To identify key residues and interactions involved in BmP02's inhibition of Kv1.3.
• To provide a structural basis for designing novel Kv1.3 inhibitors.

Main Methods:

• Molecular docking and molecular dynamics simulations to model the Kv1.3-BmP02 complex.
• Scanning alanine mutagenesis of BmP02 to identify critical residues for Kv1.3 interaction.
• Site-directed mutagenesis of Kv1.3 residues (D421, D422) to assess their role in BmP02 binding.

Main Results:

• Molecular modeling identified the β-turn (residues 10-16) of BmP02 as the primary binding interface with Kv1.3.
• Mutagenesis confirmed His9, Lys11, and Lys13 in BmP02's β-turn are essential for Kv1.3 interaction.
• Kv1.3 residues Asp421 and Asp422 in the turret region were identified as the binding site for BmP02, with mutations reducing inhibition sensitivity.
• Electrostatic interactions between BmP02 and Kv1.3 are critical for the inhibitory effect.

Conclusions:

• This study reveals the molecular basis for Kv1.3 recognition by the scorpion peptide BmP02.
• A novel interaction model for Kv channel-specific blocker complexes was established.
• Findings provide a foundation for the rational drug design of Kv1.3 inhibitors for treating channelopathies and autoimmune diseases.